Abstract
PEDIARIX is the first pentavalent combination vaccine licensed for use in infants in the USA. This vaccine is indicated for the prevention of diphtheria, tetanus, pertussis, hepatitis B and poliovirus. This article reviews the available data regarding the vaccine's immunogenicity and safety.
MeSH terms
-
Clinical Trials as Topic*
-
Diphtheria-Tetanus-Pertussis Vaccine
-
Hepatitis B Vaccines
-
Humans
-
Infant
-
Poliovirus Vaccine, Inactivated
-
Vaccines, Combined / administration & dosage*
-
Vaccines, Combined / adverse effects
-
Vaccines, Combined / immunology*
Substances
-
Diphtheria-Tetanus-Pertussis Vaccine
-
Hepatitis B Vaccines
-
PEDIARIX
-
Poliovirus Vaccine, Inactivated
-
Vaccines, Combined